Holen Sie sich die Stockscreener-App
108.06
1.43%
1.52
Handel nachbörslich:
108.06
Lemaitre Vascular Inc Aktie (LMAT) Neueste Nachrichten
LeMaitre Vascular (LMAT) president sells 3,311.68 shares in open market trade - Stock Titan
Kennedy Capital Management LLC Has $18.89 Million Holdings in LeMaitre Vascular, Inc. $LMAT - MarketBeat
3 Healthcare Stocks to Avoid in 2026: Analysis of UnderperformersNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Announces Quarterly Dividend of $0.25 - MarketBeat
First Trust Advisors LP Grows Stock Holdings in LeMaitre Vascular, Inc. $LMAT - MarketBeat
Stronger 2025 Results, Higher Dividend and Buyback Might Change The Case For Investing In LeMaitre Vascular (LMAT) - simplywall.st
Avoiding Lag: Real-Time Signals in (LMAT) Movement - Stock Traders Daily
LeMaitre Vascular Stock Forms Golden Cross, Signals Bullish Breakout Ahead - Markets Mojo
LeMaitre Vascular Experiences Revision in Its Stock Evaluation Amid Competitive Market Dynamics - Markets Mojo
Is LeMaitre Vascular Inc. stock a safe haven assetTrade Exit Summary & Verified Momentum Watchlists - Naître et grandir
Is LeMaitre Vascular Inc stock showing strong momentumMarket Trend Review & Low Risk Entry Point Guides - baoquankhu1.vn
LeMaitre Vascular Hits Day High with 24.41% Surge in Stock Price - Markets Mojo
LeMaitre Vascular, Inc. $LMAT Shares Sold by JPMorgan Chase & Co. - MarketBeat
LeMaitre Vascular Stock: Why Wall Street Sees $109 Mean Target - TIKR.com
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Average Rating of "Hold" from Analysts - MarketBeat
LeMaitre Vascular Experiences Revision in Stock Evaluation Amid Strong Performance Metrics - Markets Mojo
LeMaitre Vascular Hits New 52-Week High at $115.33, Up 46.41% - Markets Mojo
LMAT SEC FilingsLemaitre Vasculr 10-K, 10-Q, 8-K Forms - Stock Titan
LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Strong Buy Ratings Amid Steady Revenue Growth - DirectorsTalk Interviews
Lemaitre Vascular SVP Kamke sells $115k in LMAT stock By Investing.com - Investing.com Australia
LeMaitre (NASDAQ: LMAT) director gains PSU-based stock and dividend rights - Stock Titan
LeMaitre Vascular (NASDAQ:LMAT) CEO Sells $6,029,813.30 in Stock - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Director Sells $903,955.20 in Stock - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) CEO Sells $16,014,000.00 in Stock - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Insider Sells $115,142.76 in Stock - MarketBeat
Lemaitre Vascular SVP Kamke sells $115k in LMAT stock - Investing.com
LeMaitre Vascular (LMAT) president reports sale of 8,464 shares - Stock Titan
LeMaitre Vascular (LMAT) director gains stock through PSU vesting and dividend rights - Stock Titan
LMAT (LMAT) CEO LeMaitre reports 205,930-share sale, PSU vesting and gift - Stock Titan
George W. LeMaitre sells 150,000 shares (LMAT) in Form 144 - Stock Titan
LeMaitre Vascular (LMAT)'s Technical Outlook is Bright After Key Golden Cross - sharewise.com
LeMaitre Vascular (LMAT) Is Up 16.4% After Dividend Hike And Buyback Plan – Has The Bull Case Changed? - Yahoo Finance
LeMaitre Vascular (LMAT) Shows Promising Technical Prospects Following Significant Golden Cross - Bitget
How The LeMaitre Vascular (LMAT) Investment Story Is Evolving With New Targets And Guidance - Yahoo Finance
LeMaitre Vascular Links Strong 2025 Results To Higher Shareholder Returns - simplywall.st
LeMaitre Vascular, Inc. (LMAT): A Bull Case Theory - Yahoo Finance
LMAT: Morgan Stanley Smith Barney files Form 144 for vested restricted shares (LMAT) - Stock Titan
LeMaitre Vascular Announces Participation in Investor Conferences Scheduled for March 2026 - geneonline.com
LeMaitre Vascular: The Compounder Keeps Compounding (NYSE:MDT) - Seeking Alpha
LeMaitre to Participate at Upcoming Investor Conferences in March - marketscreener.com
Five investor conferences spotlight LeMaitre in busy March - Stock Titan
[144] LEMAITRE VASCULAR INC SEC Filing - Stock Titan
LeMaitre Vascular (LMAT) Margin Expansion Challenges Cautious Growth Narratives After FY 2025 Results - simplywall.st
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q4 2025 Earnings Call Transcript - Insider Monkey
LeMaitre Vascular Stock Surges 24% After Q4 Sales Beat. Is the $104 Street Target Still in Play? - TIKR.com
LeMaitre Vascular Q4 2025 Earnings: Revenue & Profit Exceed ExpectationsNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform
LeMaitre Vascular stock reaches 52-week high at 103.05 USD By Investing.com - Investing.com Australia
Decoding LeMaitre Vascular Inc (LMAT): A Strategic SWOT Insight - GuruFocus
LeMaitre Vascular (LMAT) Gets Price Target Boost from Barrington Research | LMAT Stock News - GuruFocus
LeMaitre Vascular (NASDAQ:LMAT) Price Target Raised to $105.00 - MarketBeat
LeMaitre Vascular stock reaches 52-week high at 103.05 USD - Investing.com South Africa
LeMaitre Vascular Q4 2025 Earnings Beat, Provides Strong 2026 OutlookNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform
LeMaitre Sees Growth Surge with Promising Earnings, Revenue Outlook - StocksToTrade
LMAT Analyst Rating: Roth Capital Reiterates and Raises Price Ta - GuruFocus
Roth Mkm Reaffirms Buy Rating for LeMaitre Vascular (NASDAQ:LMAT) - MarketBeat
Breaking Down LeMaitre Vascular: 4 Analysts Share Their Views - Benzinga
LeMaitre Vascular Shares Rise After Barrington Price Target Boost, Q4 Results - marketscreener.com
LeMaitre (LMAT) Stock Trades Up, Here Is Why - Finviz
LMAT Price Target Raised by Wells Fargo | LMAT Stock News - GuruFocus
0.97%
1.61%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):